生命科学资讯

First-movers respond to herding; BioMarin vets start new biotech; GSK buys RAPT Therapeutics; and more

Novo's Wegovy pill off to a solid start after just two weeks on market

EU kicks off one-year pilot to expedite multinational trials

ACIP members depict diverging goals after schedule change

F2G CEO outlines biotech's FDA resubmission plans, funding and expansion

Sanofi's Phase 3 eczema data cloud hopes for potential immunology blockbuster

Lilly was the only pharma bidder for Ventyx

Insurance CEOs defend their businesses at House hearing

Former FDA deputies land at Lilly, AbbVie; Italy's Angelini has a new CEO

High court picked Hikma’s ‘skinny label’ fight after letting the issue ‘percolate’

Drugmakers spent less on Washington lobbying in 2025's final quarter

Corcept's drug extends patients' lives in key ovarian cancer study

China-founded pharma Corxel raises up to $287M for oral GLP-1

Health insurance CEOs head to DC

Roche boosts NC factory investment to $2B; Rentschler CEO steps down

Another biopharma tried buying Amicus before BioMarin's $4.8B deal

Bristol Myers signs deal with Janux on T cell engager for $50M upfront

Erasca, Corvus, BioAge target $500M+ offerings

The status of EU drug price talks depends on who you ask